Klinman DM - Search Results

1

IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice.

Hodge DL, Berthet C, Coppola V, Kastenmüller W, Buschman MD, Schaughency PM, Shirota H, Scarzello AJ, Subleski JJ, Anver MR, Ortaldo JR, Lin F, Reynolds DA, Sanford ME, Kaldis P, Tessarollo L, Klinman DM, Young HA. Hodge DL, et al. Among authors: klinman dm. J Autoimmun. 2014 Sep;53:33-45. doi: 10.1016/j.jaut.2014.02.003. Epub 2014 Feb 28. J Autoimmun. 2014. PMID: 24583068 Free PMC article.

2

TLR-9 agonist immunostimulatory sequence adjuvants linked to cancer antigens.

Shirota H, Klinman DM. Shirota H, et al. Among authors: klinman dm. Methods Mol Biol. 2014;1139:337-44. doi: 10.1007/978-1-4939-0345-0_27. Methods Mol Biol. 2014. PMID: 24619691 Free PMC article.

3

Bone marrow and thymus expression of interferon-gamma results in severe B-cell lineage reduction, T-cell lineage alterations, and hematopoietic progenitor deficiencies.

Young HA, Klinman DM, Reynolds DA, Grzegorzewski KJ, Nii A, Ward JM, Winkler-Pickett RT, Ortaldo JR, Kenny JJ, Komschlies KL. Young HA, et al. Among authors: klinman dm. Blood. 1997 Jan 15;89(2):583-95. Blood. 1997. PMID: 9002962 Free article.

4

Contribution of IRF-3 mediated IFNbeta production to DNA vaccine dependent cellular immune responses.

Shirota H, Petrenko L, Hattori T, Klinman DM. Shirota H, et al. Among authors: klinman dm. Vaccine. 2009 Mar 26;27(15):2144-9. doi: 10.1016/j.vaccine.2009.01.134. Epub 2009 Feb 10. Vaccine. 2009. PMID: 19356618 Free PMC article.

5

A novel role for IL-22R1 as a driver of inflammation.

Savan R, McFarland AP, Reynolds DA, Feigenbaum L, Ramakrishnan K, Karwan M, Shirota H, Klinman DM, Dunleavy K, Pittaluga S, Anderson SK, Donnelly RP, Wilson WH, Young HA. Savan R, et al. Among authors: klinman dm. Blood. 2011 Jan 13;117(2):575-84. doi: 10.1182/blood-2010-05-285908. Epub 2010 Oct 22. Blood. 2011. PMID: 20971950 Free PMC article.

6

CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity.

Shirota H, Klinman DM. Shirota H, et al. Among authors: klinman dm. Cancer Immunol Immunother. 2011 May;60(5):659-69. doi: 10.1007/s00262-011-0973-y. Epub 2011 Feb 4. Cancer Immunol Immunother. 2011. PMID: 21318638 Free PMC article.

7

Effect of CpG ODN on monocytic myeloid derived suppressor cells.

Shirota H, Klinman DM. Shirota H, et al. Among authors: klinman dm. Oncoimmunology. 2012 Aug 1;1(5):780-782. doi: 10.4161/onci.19731. Oncoimmunology. 2012. PMID: 22934281 Free PMC article.

8

Recent progress concerning CpG DNA and its use as a vaccine adjuvant.

Shirota H, Klinman DM. Shirota H, et al. Among authors: klinman dm. Expert Rev Vaccines. 2014 Feb;13(2):299-312. doi: 10.1586/14760584.2014.863715. Epub 2013 Nov 26. Expert Rev Vaccines. 2014. PMID: 24308579 Free PMC article. Review.

9

Potential of transfected muscle cells to contribute to DNA vaccine immunogenicity.

Shirota H, Petrenko L, Hong C, Klinman DM. Shirota H, et al. Among authors: klinman dm. J Immunol. 2007 Jul 1;179(1):329-36. doi: 10.4049/jimmunol.179.1.329. J Immunol. 2007. PMID: 17579053

10

Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cells.

Shirota Y, Shirota H, Klinman DM. Shirota Y, et al. Among authors: klinman dm. J Immunol. 2012 Feb 15;188(4):1592-9. doi: 10.4049/jimmunol.1101304. Epub 2012 Jan 9. J Immunol. 2012. PMID: 22231700 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

318 results

Search Page